88 Oral etoposide (VP-16) every 3 wks. or continuously to elderly patients with small cell lung cancer (SCLC): Preliminary results of a randomized study

Publisher Website
Google Scholar
Abstract
No abstract available

This publication has 0 references indexed in Scilit: